SOST and chronic kidney disease: The association with VC may be important, as outlined in a further study demonstrating that serum sclerostin levels correspond with an increased risk of both fatal and non-fatal cardiovascular events in a non-dialysis CKD population, even after multiple statistical adjustments [156].